Sign in
4

Changes in Ownership

DEXCOM INC Filed Acc 0001093557-25-000218

Director sold 2,750 shares at $83.13 ($228,605)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
FOLETTA MARK G Director 2025-06-16 Sale 10b5-1 −2,750 $83.13 $228,605 56,621 I: show line 1 in the form
Open-market sales · 2,750 sh · avg $83.13 · $228,605
Loading xslF345X05/wk-form4_1750278712.xml…